← Evidence map

ArticlePharmacoEconomics2025

The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer's Disease in Sweden.

Xin Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40730714